A Randomized, Controlled Trial of Adding Intravenous Pantoprazole to Conventional Treatment for the Immediate Relief of Dyspeptic Pain.

Trial Profile

A Randomized, Controlled Trial of Adding Intravenous Pantoprazole to Conventional Treatment for the Immediate Relief of Dyspeptic Pain.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Jul 2012

At a glance

  • Drugs Aluminium hydroxide; Magnesium hydroxide; Pantoprazole; Scopolamine butylbromide
  • Indications Dyspepsia; Gastro-oesophageal reflux; Visceral pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jul 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01281501).
    • 04 Jun 2012 New trial record
    • 28 Mar 2012 Results published in the American Journal of Emergency Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top